Fresenius | FRE - Sales Revenues

Stock Price
38.80
Daily Change
-0.27 -0.69%
Monthly
-13.04%
Yearly
-10.43%
Q2 Forecast
37.79

Fresenius reported EUR5.74B in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Akzo Nobel EUR 2.39B 20M Mar/2026
Alcon AG USD 2.69B 10M Mar/2026
AstraZeneca USD 15.29B 213M Mar/2026
BASF EUR 16.02B 1.99B Mar/2026
Bayer EUR 13.41B 1.97B Mar/2026
Beiersdorf EUR 2.48B 170M Mar/2026
DaVita Healthcare Partners USD 3.42B 200M Mar/2026
Demant DKK 6.25B 800M Dec/2025
E.ON EUR 21.82B 630M Mar/2026
Essilor EUR 14.47B 7.6B Dec/2025
Fresenius EUR 5.74B 140M Mar/2026
Fresenius Medical Care EUR 4.61B 460M Mar/2026
Getinge SEK 11.07B 3.2B Dec/2024
Givaudan CHF 3.61B 256M Dec/2025
GlaxoSmithKline GBP 7.63B 991M Mar/2026
GN Store Nord DKK 3.85B 830M Mar/2026
GRIFOLS EUR 1.7B 280M Mar/2026
Hikma Pharmaceutical USD 1.69B 863M Dec/2025
Lonza CHF 3.58B 63M Jun/2025
Merck EUR 5.13B 120M Mar/2026
Novartis USD 13.11B 226M Mar/2026
Philips EUR 3.91B 1.19B Mar/2026
Roche Holding CHF 15.65B 274.5M Dec/2025
RWE EUR 4.34B 220M Mar/2026
Sanofi EUR 11.24B 60M Mar/2026
Smith & Nephew USD 3.18B 353M Dec/2025